A Phase IB/II Study of Lucitanib and Nivolumab Immunotherapy in Women with Advanced Gynecologic Cancers – On Cancer – Memorial Sloan Kettering

Source: A Phase IB/II Study of Lucitanib and Nivolumab Immunotherapy in Women with Advanced Gynecologic Cancers – On Cancer – Memorial Sloan Kettering

We’re committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more

Published at Thu, 15 Oct 2020 16:08:38 +0000